10-120851534-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_018117.12(WDR11):c.86+28A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00187 in 1,599,742 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 23 hom., cov: 33)
Exomes 𝑓: 0.00096 ( 19 hom. )
Consequence
WDR11
NM_018117.12 intron
NM_018117.12 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.132
Genes affected
WDR11 (HGNC:13831): (WD repeat domain 11) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene is located in the chromosome 10q25-26 region, which is frequently deleted in gliomas and tumors of other tissues, and is disrupted by the t(10;19) translocation rearrangement in glioblastoma cells. The gene location suggests that it is a candidate gene for the tumor suppressor locus. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 10-120851534-A-G is Benign according to our data. Variant chr10-120851534-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 1219686.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0105 (1596/152308) while in subpopulation AFR AF = 0.0366 (1523/41570). AF 95% confidence interval is 0.0351. There are 23 homozygotes in GnomAd4. There are 775 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 1596 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0105 AC: 1595AN: 152190Hom.: 23 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1595
AN:
152190
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00234 AC: 504AN: 215192 AF XY: 0.00178 show subpopulations
GnomAD2 exomes
AF:
AC:
504
AN:
215192
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000963 AC: 1394AN: 1447434Hom.: 19 Cov.: 31 AF XY: 0.000774 AC XY: 556AN XY: 718560 show subpopulations
GnomAD4 exome
AF:
AC:
1394
AN:
1447434
Hom.:
Cov.:
31
AF XY:
AC XY:
556
AN XY:
718560
Gnomad4 AFR exome
AF:
AC:
1214
AN:
33398
Gnomad4 AMR exome
AF:
AC:
51
AN:
42342
Gnomad4 ASJ exome
AF:
AC:
0
AN:
25744
Gnomad4 EAS exome
AF:
AC:
0
AN:
39298
Gnomad4 SAS exome
AF:
AC:
3
AN:
83718
Gnomad4 FIN exome
AF:
AC:
0
AN:
50874
Gnomad4 NFE exome
AF:
AC:
11
AN:
1106392
Gnomad4 Remaining exome
AF:
AC:
111
AN:
59912
Heterozygous variant carriers
0
62
124
186
248
310
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0105 AC: 1596AN: 152308Hom.: 23 Cov.: 33 AF XY: 0.0104 AC XY: 775AN XY: 74474 show subpopulations
GnomAD4 genome
AF:
AC:
1596
AN:
152308
Hom.:
Cov.:
33
AF XY:
AC XY:
775
AN XY:
74474
Gnomad4 AFR
AF:
AC:
0.036637
AN:
0.036637
Gnomad4 AMR
AF:
AC:
0.00333246
AN:
0.00333246
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.000207125
AN:
0.000207125
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000441099
AN:
0.0000441099
Gnomad4 OTH
AF:
AC:
0.00756144
AN:
0.00756144
Heterozygous variant carriers
0
81
161
242
322
403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 27, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at